C677T Polymorphism of the 5,10 MTHFR Gene in Young Mexican Subjects with ST-Elevation Myocardial Infarction

Archives of Medical Research

Volumn 41, Issue 4, 2010, Pages 246-250

  Isordia Salas, Irma ^a   Trejo Aguilar, Adriana ^a   Valadés Mejía, Ma Guadalupe ^a,b   Santiago Germán, David ^b   Leaños Miranda, Alfredo ^a   Mendoza Valdéz, Lorena ^c   Jáuregui Aguilar, Ricardo ^c   Borrayo Sánchez, Gabriela ^c   Majluf Cruz, Abraham ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^c HOSPITAL DE CARDIOLOGÍA   (Mexico)

Author keywords

Acute myocardial infarction; Atherothrombosis; C677T polymorphism; Risk factors

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); PRIMER DNA;

ADULT; ARTERY THROMBOSIS; ARTICLE; DIABETES MELLITUS; DYSLIPIDEMIA; FAMILY HISTORY; FEMALE; GENDER; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SMOKING; ST SEGMENT ELEVATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; CASE CONTROL STUDY; ENZYMOLOGY; GENETICS; MEXICO; NUCLEOTIDE SEQUENCE;

ADULT; BASE SEQUENCE; CASE-CONTROL STUDIES; DNA PRIMERS; FEMALE; GENE FREQUENCY; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MEXICO; MYOCARDIAL INFARCTION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 77954654469     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2010.04.008     Document Type: Article

References (37)

1. Yusuf S., Hawken S., Ounpuu S., et al. INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004, 364:937-952.
2. Instituto Nacional de Estadística, Geografía e Informática. Censo Nacional de Población y Vivienda 2007, (México). Available at: http://www.inegi.org.mx.
3. Kölling K., Ndrepepa G., Koch W., et al. Methylenetetrahydrofolate reductase gene C677T and A1298C polymorphisms, plasma homocysteine, folate, and vitamin B12 levels and the extent of coronary artery disease. Am J Cardiol 2004, 93:1201-1206.
4. Frosst P., Blom H.J., Milos R., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nutr Genet 1995, 10:111-113.
5. Brattström L., Wilcken D.E., Ohrvik J., et al. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. Circulation 1998, 98:2520-2526.
6. Ghazouani L., Abboud N., Mtiraoui N., et al. Homocysteine and methylenetetrahydrofolate reductase C677T and A1298C polymorphisms in Tunisian patients with severe coronary artery disease. J Thromb Thrombolysis 2009, 27:191-197.
7. Gardemann A., Weidemann H., Philipp M., et al. The TT genotype of the methylenetetrahydrofolate reductase C677T gene polymorphism is associated with the extent of coronary atherosclerosis in patients at high risk for coronary artery disease. Eur Heart J 1999, 20:584-592.
8. Gulec S., Aras O., Akar E., et al. Methylentetrahydrofolate reductase gene polymorphism and risk of premature myocardial infarction. Clin Cardiol 2001, 21:281-284.
9. Ilhan N., Kucuksu M., Kaman D., et al. The 677 C/T MTHFR polymorphism is associated with essential hypertension, coronary artery disease, and higher homocysteine levels. Arch Med Res 2008, 39:125-130.
10. Moe K.T., Woon F.P., De Silva D.A., et al. Association of acute ischemic stroke with the MTHFR C677T polymorphism but not with NOS3 gene polymorphism in a Singapur population. Eur J Neurol 2008, 15:1309-1314.
11. Kawamoto R., Kohara K., Oka Y., et al. An association of 5,10- methylenetetrahydrofolate reductase (MTHFR) gene polymorphism and ischemic stroke. J Stroke Cerebrovasc Dis 2005, 14:67-74.
12. Rallidis L.S., Gialeraki A., Komporozos C., et al. Role of methylenetetrahydrofolate reductase 677C->T polymorphism in the development of premature myocardial infarction. Atherosclerosis 2008, 200:115-120.
13. Alam M.A., Husain S.A., Narang R., et al. Association of polymorphism in the thermolabile 5,10-methylenetetrahydrofolate reductase gene and hyperhomocysteinemia with coronary artery disease. Mol Cell Biochem 2008, 310:111-117.
14. Pintó X., Vilaseca M.A., Garcia-Giralt N., et al. Homocysteine and the MTHFR 677C->T allele in premature coronary artery disease. Case control and family studies. Eur J Clin Invest 2001, 31:24-30.
15. Yilmaz H., Isbir S., Agachan B., et al. C677T mutation of methylenetetrahydrofolate reductase gene and serum homocysteine levels in Turkish patients with coronary artery disease. Cell Biochem Funct 2006, 24:87-90.
16. Guerzoni A.R., Biselli P.M., Godoy M.F., et al. Homocysteine and MTHFR and VEGF gene polymorphisms: impact on coronary artery disease. Arq Bras Cardiol 2009, 92:263-268.
17. Helfenstein T., Fonseca F.A., Relvas W.G., et al. Prevalence of myocardial infarction is related to hyperhomocysteinemia but not influenced by C677T methylenetetrahydrofolate reductase and A2756G methionine synthase polymorphisms in diabetic and non-diabetic subjects. Clin Chim Acta 2005, 355:165-172.
18. Klerk M., Verhoef P., Clarke R., et al. MTHFR 677C->T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA 2002, 288:2023-2031.
19. Lewis S.J., Ebrahim S., Davey Smith G. Meta-analysis of MTHFR 677C>T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate?. BMJ 2005, 331:1053.
20. Mutchinick O.M., López M.A., Luna L., et al. High prevalence of the thermolabile methylenetetrahydrofolate reductase variant in Mexico: a country with a very high prevalence of neural tube defects. Mol Genet Metab 1999, 68:461-467.
21. Dávalos I.P., Moran M.C., Martínez-Abundis E., et al. Methylenetetrahydrofolate reductase C677T polymorphism and factor V Leiden variant in Mexican women with preeclampsia/eclampsia. Blood Cells Mol Dis 2005, 351:66-69.
22. Zúñiga-Noriega J.R., Velazco-Campos M., del R., Aguirre-Rodríguez A., et al. C677T polymorphism of the MTHFR gene and the risk of developing distal gastric cancer in a Mexican population. Rev Gastroenterol Mex 2007, 72:355-358.
23. Dávalos I.P., Olivares N., Castillo M.T., et al. The C677T polymorphism of the methylenetetrahydrofolate reductase gene in Mexican mestizo neural-tube defect parents, control mestizo and native populations. Ann Genet 2000, 43:89-92.
24. Isordia-Salas I., Barinagarrementería-Aldatz F., Leaños-Miranda A., et al. The C677T polymorphism of the methylenetetrahydrofolate reductase gene is associated with idiopathic ischemic stroke in the young Mexican-mestizo population. Cerebrovasc Dis 2010, 29:454-459.
25. Alpert J.S., Thygesen K., Antman E., et al. Myocardial Infarction Redefined-A Consensus Document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 2000, 36:959-969.
26. Ferguson J.L., Beckett G.J., Stoddart M., et al. Myocardial infarction redefined: the new ACC/ESC definition, based on cardiac troponin, increases the apparent incidence of infarction. Heart 2002, 88:343-347.
27. US Department of Health and Human Services National High Blood Pressure Education Program. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. NIH Publication No. 03-5233 2003, NIH, Bethesda, MD.
28. American Diabetes Association/American College of Cardiology Diabetic dyslipidemia 2002, Available at:. http://www.diabetes.org/uedocuments/ADACardioReview3.
29. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2005, 8:S37-S42.
30. Verhoef P., Kok F.J., Kluijtmans L.A., et al. The 677C->T mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease. Atherosclerosis 1997, 132:105-113.
31. Iqbal M.P., Fatima T., Parveen S., et al. Lack of association of methylenetetrahydrofolate reductase 677C>T mutation with coronary artery disease in a Pakistani population. J Mol Genet Med 2005, 1:26-32.
32. Schwartz S.M., Siscovick D.S., Malinow M.R., et al. Myocardial infarction in young women in relation to plasma total homocysteine, folate, and a common variant in the methylenetetrahydrofolate reductase gene. Circulation 1997, 96:412-417.
33. Christensen B., Frosst P., Lussier-Cacan S., Selhub J., et al. Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease. Arterioscler Thromb Vasc Biol 1997, 17:569-573.
34. Franco R.F., Araujo A.G., Guerreiro J.F., et al. Analysis of the 677→C mutation of the methylenetetrahydrofolate reductase gene in different ethnic groups. Thromb Haemost 1998, 79:119-121.
35. Montaño-Loza A., Meza-Junco J., Valles V., et al. Plasma homocysteine concentrations in Mexican patients with ischemic heart disease. Rev Invest Clin 2004, 56:580-585.
36. Isordia-Salas I., Leaños-Miranda A., Sainz I.M., et al. Association of the plasminogen activator inhibitor-1 gene 4G/5G polymorphism with ST elevation acute myocardial infarction in young patients. Rev Esp Cardiol 2009, 62:365-372.
37. Isordia-Salas I., Leaños-Miranda A., Borrayo-Sánchez G. The Glu298ASP polymorphism of the endothelial nitric oxide synthase gene is associated with premature ST elevation myocardial infarction in Mexican population. Clin Chim Acta 2010, 411. 553-537.